Heat shock proteins: Stress proteins with Janus-like properties in cancer

International Journal of Hyperthermia

Volumn 24, Issue 1, 2008, Pages 31-39

  Calderwood, Stuart K ^a   Ciocca, Daniel R ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b INSTITUTO ARGENTINO DE NIVOLOGÍA   (Argentina)

Author keywords

Apoptosis; Cancer; Heat shock protein; Immunity; Thermotolerance; Tumor

Indexed keywords

CANCER VACCINE; CHAPERONE; DENDRITIC CELL VACCINE; DNA VACCINE; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 40; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; HEAT SHOCK PROTEIN 90 INHIBITOR; JANUS KINASE; SYNTHETIC PEPTIDE; THYMIDINE KINASE; TUMOR ANTIGEN;

ANTIGEN PRESENTATION; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER CELL; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER IMMUNOTHERAPY; CARCINOGENESIS; CELL DEATH; CELL SURVIVAL; CLINICAL TRIAL; CONFERENCE PAPER; DRUG DOSE COMPARISON; DRUG TARGETING; HEAT TOLERANCE; HIGH TEMPERATURE; HUMAN; HYPERTHERMIC THERAPY; IMMUNE SYSTEM; IMMUNOGENICITY; NEOPLASM; NONHUMAN; PHENOTYPIC VARIATION; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SUICIDE GENE THERAPY;

APOPTOSIS; COMBINED MODALITY THERAPY; HEAT-SHOCK PROTEINS; HUMANS; HYPERTHERMIA, INDUCED; IMMUNOTHERAPY; NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 38649094249     PISSN: 02656736     EISSN: 14645157     Source Type: Journal    
DOI: 10.1080/02656730701858305     Document Type: Conference Paper

References (96)

1. Ellis, RJ (2006) Molecular chaperones: Assisting assembly in addition to folding. Trends Biochem Sci, 31, pp. 395-401.
2. Ritossa, F. (1962) A new puffing pattern induced by temperature shock and DNP in Drosophila. Experientia, 18, pp. 571-573.
3. Ashburner, M. (1982) The effects of heat shock and other stresses on gene activity: An introduction, Cold Spring Harbor laboratory Publications, Cold Spring Harbor Laboratory
4. Barnett, TM, Altschuler, CN and McDaniel, CN (1980) Heat shock induced proteins in plant cells. Dev Genet, 1, pp. 331-340.
5. Bouche, G., Amalric, F. and Caizergues-Ferrer, M. (1979) Effects of heat shock on gene expression and subcellular protein distribution in Chinese hamster ovary cells. Nucleic Acids Res, 7, pp. 1739-1747.
6. Kelley, PM and Schlesinger, MJ (1978) The effect of amino acid analogues and heat shock on gene expression in chicken embryo fibroblasts. Cell, 15, pp. 1277-1286.
7. Lemeaux, PG, Herendeen, SL and Bloch, PL (1978) Transient rates of synthesis of individual polypeptides in E. coli following temperature shifts. Cell, 13, pp. 427-434.
8. Miller, MJ, Xuong, N-H and Geiduschek, EP (1979) A response of protein synthesis to temperature shift in the yeast Saccharomyces cerevisiae. Proc Nat Acad Sci USA, 76, pp. 1117-1121.
9. Hightower, LE and White, FP (1981) Cellular responses to stress: comparison of a family of 71-73-kilodalton proteins rapidly synthesized in rat tissue slices and canavanine-treated cells in culture. J Cell Physiol, 108, pp. 261-275.
10. Georgopolis, C. and Welch, WJ (1993) Role of the major heat shock proteins as molecular chaperones. Ann Rev Cell Biol, 9, pp. 601-634.
11. Schlossman, DM, Schmid, SL and Braell, WA (1984) An enzyme that removes clathrin coats: Purification of an uncoating ATPase. J Cell Biol, 99, pp. 723-733.
12. Pelham, HR and Bienz, M. (1982) A synthetic heat-shock promoter element confers heat-inducibility on the herpes simplex virus thymidine kinase gene. Embo J, 1, pp. 1473-1477.
13. Sorger, PK and Pelham, HR (1988) Yeast heat shock factor is an essential DNA-binding protein that exhibits temperature-dependent phosphorylation. Cell, 54, pp. 855-864.
14. Wu, C. (1995) Heat shock transcription factors: Structure and regulation. Ann Rev Cell Dev Biol, 11, pp. 441-469.
15. Picard, D., Khursheed, B. and Garabedian, MJ (1990) Reduced levels of Hsp90 compromise steroid receptor action in vivo. Nature, 348, pp. 166-168.
16. Pratt, WB and Toft, DO (2003) Regulation of signaling protein function and trafficking by the Hsp90/hsp70-based chaperone machinery. Exp Biol Med (Maywood), 228, pp. 111-133.
17. Connell, P., Ballinger, CA and Jiang, J. (2001) The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins. Nat Cell Biol, 3, pp. 93-96.
18. Li, GC and Hahn, GM (1981) A proposed operational model for thermotolerance. Cancer Research, 40, pp. 4501-4508.
19. Subjeck, JR, Sciandra, JJ and Johnson, RJ (1982) Heat shock proteins and thermotolerance; a comparison of induction kinetics. Br J Radiol, 55, pp. 579-584.
20. Li, GC and Werb, Z. (1982) Correlation between the synthesis of heat shock proteins and the development of thermotolerance in CHO fibroblasts. Proc Nat Academy of Sci USA, 79, pp. 3218-3222.
21. Landry, J., Bernier, D. and Chretien, P. (1982) Synthesis and degradation of heat shock proteins during the development and decay of thermotolerance. Cancer Research, 42, pp. 2457-2461.
22. Sapareto, S. and Dewey, WC (1984) Thermal dose determination in cancer therapy. Int J Radiat Oncol Biol Phys, 10, pp. 787-800.
23. Kampinga, HH, Brunsting, JF and Stege, GJ (1995) Thermal protein denaturation and protein aggregation in cells made thermotolerant by various chemicals: Role of heat shock proteins. Exp Cell Res, 219, pp. 536-546.
24. Kampinga, HH, Brunsting, JF and Stege, GJ (1994) Cells overexpressing Hsp27 show accelerated recovery from heat-induced nuclear protein aggregation. Biochem Biophys Res Commun, 204, pp. 1170-1177.
25. Buchner, J. (1999) Hsp90 & Co.-A holding for folding. TIBS, 24, pp. 136-142.
26. Wegele, H., Muller, L. and Buchner, J. (2004) Hsp70 and Hsp90-A relay team for protein folding. Rev Physiol Biochem Pharmacol, 151, pp. 1-44.
27. Gabai, VL, Meriin, AB and Mosser, DD (1997) Hsp70 prevents activation of stress kinases. A novel pathway of cellular thermotolerance. J Biol Chem, 272, pp. 18033-18037.
28. Gabai, VL, Meriin, AB and Yaglom, JA (1998) Role of Hsp70 in regulation of stress-kinase JNK: Implications in apoptosis and aging. FEBS Lett, 438, pp. 1-4.
29. Daugaard, M., Rohde, M. and Jaattela, M. (2007) The heat shock protein 70 family: Highly homologous proteins with overlapping and distinct functions. FEBS Lett, 581, pp. 3702-3710.
30. Ciocca, DR and Calderwood, SK (2005) Heat shock proteins in cancer: Diagnostic, prognostic, predictive, and treatment applications. Cell Stress Chaperones, 10, pp. 86-103.
31. Calderwood, SK, Khaleque, MA and Ciocca, DR (2007) Heat shock proteins in the progression of cancer, 7, Springer, New York
32. Calderwood, SK, Khaleque, MA and Sawyer, DB (2006) Heat shock proteins in cancer: Chaperones of tumorigenesis. Trends Biochem Sci, 31, pp. 164-172.
33. Wu, G., Osada, M. and Guo, Z. (2005) DeltaNp63alpha up-regulates the Hsp70 gene in human cancer. Cancer Res, 65, pp. 758-766.
34. Taira, T., Sawai, M. and Ikeda, M. (1999) Cell cycle-dependent switch of up- and down-regulation of human Hsp70 gene expression by interaction between c-Myc and CBF/NF-Y. J Biol Chem, 274, pp. 24270-24279.
35. Tsutsumi-Ishii, Y., Tadokoro, K. and Hanaoka, F. (1995) Response of heat shock element within the human Hsp70 promoter to mutated p53 genes. Cell Growth Diff, 6, pp. 1-8.
36. Madden, SL, Galella, EA and Zhu, J. (1997) SAGE transcript profiles for p53-dependent growth regulation. Oncogene, 15, pp. 1079-1085.
37. Ghioni, P., Bolognese, F. and Duijf, PH (2002) Complex transcriptional effects of p63 isoforms: Identification of novel activation and repression domains. Mol Cell Biol, 22, pp. 8659-8668.
38. Agoff, SN, Hou, J. and Linzer, DI (1993) Regulation of the human Hsp70 promoter by p53. Science, 259, pp. 84-87.
39. Khaleque, MA, Bharti, A. and Sawyer, D. (2005) Induction of heat shock proteins by heregulin beta1 leads to protection from apoptosis and anchorage-independent growth. Oncogene, 24, pp. 6564-6573.
40. Lindquist, S. and Craig, EA (1988) The heat shock proteins. Ann Rev Genet, 22, pp. 631-637.
41. Bader, AG, Kang, S. and Zhao, L. (2005) Oncogenic PI3K deregulates transcription and translation. Nat Rev Cancer, 5, pp. 921-929.
42. Teng, SC, Chen, YY and Su, YN (2004) Direct activation of Hsp90A transcription by c-Myc contributes to c-Myc-induced transformation. J Biol Chem, 279, pp. 14649-14655.
43. Wang, Y., Theriault, JR and He, H. (2004) Expression of a dominant negative heat shock factor-1 construct inhibits aneuploidy in prostate carcinoma cells. J Biol Chem, 279, pp. 32651-32659.
44. Hoang, AT, Huang, J. and Rudra-Ganguly, N. (2000) A novel association between the human heat shock transcription factor 1 (HSF1) and prostate adenocarcinoma. Am J Pathol, 156, pp. 857-864.
45. Zou, J., Guo, Y. and Guettouche, T. (1998) Repression of heat shock transcription factor HSF1 activation by Hsp90 (Hsp90 complex) that forms a stress-sensitive complex with HSF1. Cell, 94, pp. 471-480.
46. Arrigo, AP (2005) Heat shock proteins as molecular chaperones.21, pp. 619-625.
47. Farooqui-Kabir, SR, Budhram-Mahadeo, V. and Lewis, H. (2004) Regulation of Hsp27 expression and cell survival by the POU transcription factor Brn3a. Cell Death Differ, 11, pp. 1242-1244.
48. Lee, SA, Ndisang, D. and Patel, C. (2005) Expression of the Brn-3b transcription factor correlates with expression of Hsp27 in breast cancer biopsies and is required for maximal activation of the Hsp27 promoter. Cancer Res, 65, pp. 3072-3080.
49. Folkman, J. (2002) Role of angiogenesis in tumor growth and metastasis. Semin Oncol, 29, pp. 15-18.
50. Tang, D., Khaleque, AA and Jones, ER (2005) Expression of heat shock proteins and HSP messenger ribonucleic acid in human prostate carcinoma in vitro and in tumors in vivo. Cell Stress Chaperones, 10, pp. 46-59.
51. Beere, HM (2001) Stressed to death: Regulation of apoptotic signaling pathways by the heat shock proteins. Sci STKE
52. Nylandsted, J., Brand, K. and Jaattela, M. (2000) Heat shock protein 70 is required for the survival of cancer cells. Ann NY Acad Sci, 926, pp. 122-125.
53. Tenniswood, MP, Guenette, RS and Lakins, J. (1992) Active cell death in hormone-dependent tissues. Cancer Metastasis Rev, 11, pp. 197-220.
54. Paul, C., Manero, F. and Gonin, S. (2002) Hsp27 as a negative regulator of cytochrome C release. Mol Cell Biol, 22, pp. 816-834.
55. Hanahan, D. and Weinberg, RA (2000) The hallmarks of cancer. Cell, 100, pp. 57-70.
56. Nelson, DA and White, E. (2004) Exploiting different ways to die. Genes Dev, 18, pp. 1223-1226.
57. Jaattela, M. (2004) Multiple cell death pathways as regulators of tumour initiation and progression. Oncogene, 23, pp. 2746-2756.
58. Proskuryakov, SY, Konoplyannikov, AG and Gabai, VL (2003) Necrosis: A specific form of programmed cell death?. Exp Cell Res, 283, pp. 1-16.
59. Viatour, P., Merville, MP and Bours, V. (2005) Phosphorylation of NF-kappaB and IkappaB proteins: Implications in cancer and inflammation. Trends Biochem Sci, 30, pp. 43-52.
60. Ciocca, DR, Oesterreich, S. and Chamness, GC (1993) Biological and clinical implications of heat shock protein 27,000 (Hsp27): A review. J Natl Cancer Inst, 85, pp. 1558-1570.
61. Neckers, L. and Ivy, SP (2003) Heat shock protein 90. Curr Opin Oncol, 15, pp. 419-424.
62. Pratt, WB, Galigniana, MD and Harrell, JM (2004) Role of Hsp90 and the Hsp90-binding immunophilins in signalling protein movement. Cell Signal, 16, pp. 857-872.
63. Zhou, V., Han, S. and Brinker, A. (2004) A time-resolved fluorescence resonance energy transfer-based HTS assay and a surface plasmon resonance-based binding assay for heat shock protein 90 inhibitors. Anal Biochem, 331, pp. 349-357.
64. Grammatikakis, N., Vultur, A. and Ramana, CV (2002) The role of Hsp90N, a new member of the Hsp90 family, in signal transduction and neoplastic transformation. J Biol Chem, 277, pp. 8312-8320.
65. Pearl, LH (2005) Hsp90 and Cdc37-A chaperone cancer conspiracy. Curr Opin Genet Dev, 15, pp. 55-61.
66. Scheibel, T. and Buchner, J. (1998) The Hsp90 complex-A super-chaperone machine as a novel drug target. Biochem Pharmacol, 56, pp. 675-682.
67. Neckers, L. (2002) Hsp90 inhibitors as novel cancer chemotherapeutic agents. Trends Mol Med, 8, p. S55.
68. Neckers, L. and Lee, YS (2003) Cancer: The rules of attraction. Nature, 425, pp. 357-359.
69. Kamal, A., Thao, L. and Sensintaffar, J. (2003) A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors. Nature, 425, pp. 407-410.
70. Calderwood, SK, Theriault, JR and Gong, J. (2005) Message in a bottle: Role of the 70-kDa heat shock protein family in anti-tumor immunity. Eur J Immunol, 35, pp. 2518-2527.
71. Calderwood, SK, Theriault, JR and Gong, J. (2005) How is the immune response affected by hyperthermia and heat shock proteins?. Int J Hyperthermia, 21, pp. 713-716.
72. Srivastava, P. (2002) Interaction of heat shock proteins with peptides and antigen presenting cells: Chaperoning of the innate and adaptive immune responses. Annu Rev Immunol, 20, pp. 395-425.
73. Srivastava, P. (2003) Hypothesis: Controlled necrosis as a tool for immunotherapy of human cancer. Cancer Immun, 3, p. 4.
74. Srivastava, PK (2000) Immunotherapy of human cancer: Lessons from mice. Nat Immunol, 1, pp. 363-366.
75. Belli, F., Testori, A. and Rivoltini, L. (2002) Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes: Clinical and immunologic findings. J Clin Oncol, 20, pp. 4169-4180.
76. Mazzaferro, V., Coppa, J. and Carrabba, MG (2003) Vaccination with autologous tumor-derived heat-shock protein gp96 after liver resection for metastatic colorectal cancer. Clin Cancer Res, 9, pp. 3235-3245.
77. Srivastava, PK (2006) Therapeutic cancer vaccines. Curr Opin Immunol, 18, pp. 201-205.
78. Rosenberg, SA, Yang, JC and Restifo, NP (2004) Cancer Immunotherapy: Moving beyond current vaccines. Nature Medicine, 10, pp. 909-915.
79. Manjili, MH, Wang, XY and Chen, X. (2003) Hsp110-HER2/neu chaperone complex vaccine induces protective immunity against spontaneous mammary tumors in HER-2/neu transgenic mice. J Immunol, 171, pp. 4054-4061.
80. Segal, BH, Wang, XY and Dennis, CG (2006) Heat shock proteins as vaccine adjuvants in infections and cancer. Drug Discov Today, 11, pp. 534-540.
81. Rock, KL, Hearn, A. and Chen, CJ (2005) Natural endogenous adjuvants. Springer Semin Immunopathol, 26, pp. 231-246.
82. Shen, L. and Rock, KL (2006) Priming of T cells by exogenous antigen cross-presented on MHC class I molecules. Curr Opin Immunol, 18, pp. 85-91.
83. Zeng, Y., Graner, MW and Katsanis, E. (2006) Chaperone-rich cell lysates, immune activation and tumor vaccination. Cancer Immunol Immunother, 55, pp. 329-338.
84. Enomoto, Y., Bharti, A. and Khaleque, A. (2006) Enhanced immunogenicity of Hsp70 peptide complexes from DC-tumor fusion cells requires Myd-88. J Immunol
85. Rosenberg, SA (2004) Shedding light on tumor immunotherapy of cancer. NEJM, 350, pp. 1461-1463.
86. Daniels, GA, Sanchez-Perez, L. and Diaz, RM (2004) A simple method to cure established tumors by inflammatory killing of normal cells. Nat Biotechnol, 22, pp. 1125-1132.
87. Calderwood, SK (2005) Chaperones and slow death-A recipe for tumor immunotherapy. Trends Biotechnol, 23, pp. 57-59.
88. Engelhard, VH, Bullock, TN and Colella, TA (2002) Antigens derived from melanocyte differentiation proteins: Self-tolerance, autoimmunity, and use for cancer immunotherapy. Immunol Rev, 188, pp. 136-146.
89. Todryk, S., Melcher, AA and Hardwick, N. (1999) Heat shock protein 70 induced during tumor cell killing induces Th1 cytokines and targets immature dendritic cell precursors to enhance antigen uptake. J Immunol, 163, pp. 1398-1408.
90. Huang, XF, Ren, W. and Rollins, L. (2003) A broadly applicable, personalized heat shock protein-mediated oncolytic tumor vaccine. Cancer Res, 63, pp. 7321-7329.
91. Repasky, E. and Issels, R. (2002) Physiological consequences of hyperthermia: Heat, heat shock proteins and the immune response. Int J Hyperthermia, 18, pp. 486-489.
92. Mambula, SS and Calderwood, SK (2006) Heat shock protein 70 is secreted from tumor cells by a nonclassical pathway involving lysosomal endosomes. J Immunol, 177, pp. 7849-7857.
93. Evans, SS, Wang, WC and Bain, MD (2001) Fever-range hyperthermia dynamically regulates lymphocyte delivery to high endothelial venules. Blood, 97, pp. 2727-2733.
94. Chen, Q., Fisher, DT and Clancy, KA (2006) Fever-range thermal stress promotes lymphocyte trafficking across high endothelial venules via an interleukin 6 trans-signaling mechanism. Nat Immunol, 12, pp. 1299-1308.
95. Ciocca, DR, Frayssinet, P. and Cuello-Carrión, FD (2007) A pilot study with a therapeutic vaccine based on hydroxyapatite ceramic particles and self-antigens in cancer patients. Cell Stress Chaperones, 12, pp. 33-43.
96. Bonorino, C. and Souza, AP (2007) Hsp70 in tumors: Friend or foe?. Heat shock proteins in biology and medicine, Springer, New York